CCF 2021 - 2021 Cholangiocarcinoma Foundation Annual Conference (Virtual Meeting)
Mar 31 - Apr 02, 2021 | Salt Lake CityUTUS
LARVOL is not affiliated with 2021 Cholangiocarcinoma Foundation Annual Conference (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 4 abstracts linked to Trials
[VIRTUAL] A phase II study of pembrolizumab in combination with capecitabine and cxaliplatin in advanced biliary tract cancer
[VIRTUAL] Futibatinib in patients with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements: FOENIX-CCA2
[VIRTUAL] Results from the Ph 1 study of Zanidatamab in HER2-expressing biliary tract cancers & design of HERIZON-BTC-01 (Ph 2) study
[VIRTUAL] A phase 2 study of infigratinib in previously-treated advanced cholangiocarcinoma with FGFR2 gene fusions/rearrangements